ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

ADALIMUMABUM

Active substance (INN) · ATC L04AB04 · 19 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
L039M ARTRITA IDIOPATICĂ JUVENILĂ - AGENŢI BIOLOGICI: ADALIMUMABUM**1 (original și biosimilar), ETANERCEPTUM**1 (original și biosimilar), ABATACEPTUM**1, TOCILIZUMABUM**1(origi… In force medicine of the protocol C1-G31E NO
L040M ARTRITA PSORIAZICĂ – AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM**1, ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), GOLIMUMABUM**1, INFLIXIMABUM… In force medicine of the protocol C1-G31C NO
L041M SPONDILOARTRITA AXIALĂ, INCLUZÂND SPONDILITA ANCHILOZANTĂ ȘI SPONDILOARTRITA AXIALĂ NONRADIOGRAFICĂ - AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZ… In force medicine of the protocol C1-G31D NO
L043M POLIARTRITA REUMATOIDĂ - AGENŢI BIOLOGICI: INFLIXIMABUM**1 (ORIGINAL ŞI BIOSIMILAR), ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), G… In force medicine of the protocol C1-G31B NO
L04AB04-HS ADALIMUMABUM In force medicine of the protocol C1-G18 NO
L04AB04-UV ADALIMUMABUM In force medicine of the protocol C1-G18 NO
L034K BOALĂ CRONICĂ INFLAMATORIE INTESTINALĂ In force mentioned in the text C1-G31.A NO*
L044L PSORIAZIS CRONIC SEVER (ÎN PLĂCI) - AGENŢI BIOLOGICI ŞI TERAPII CU MOLECULE MICI CU ACŢIUNE INTRACELULARĂ In force mentioned in the text C1-G31F YES
2

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
AMGEVITA 40 mg/0,4 mlSOL. INJ. IN PEN PREUMPLUT40mg/0,4mlAMGEN EUROPE B.V. - OLANDAL04AB04PR
AMGEVITA 40 mg/0,4 mlSOL. INJ. IN SERINGA PREUMPLUTA40mg/0,4mlAMGEN EUROPE B.V. - OLANDAL04AB04PR
AMSPARITY 20mg/0,4mlSOL INJ. IN SERINGA PREUMPLUTA20mg/0,4mlPFIZER EUROPE MA EEIG - BELGIAL04AB04PR
AMSPARITY 40 mg/0,8 mlSOL. INJ.40mg/0,8mlPFIZER EUROPE MA EEIG - BELGIAL04AB04PR
AMSPARITY 40mg/0,8mlSOL INJ. IN SERINGA PREUMPLUTA40mg/0,8mlPFIZER EUROPE MA EEIG - BELGIAL04AB04PR
AMSPARITY 40mg/0,8mlSOL INJ. IN STILOU INJECTOR (PEN) PREUMPLUT40mg/0,8mlPFIZER EUROPE MA EEIG - BELGIAL04AB04PR
HEFIYA 40mg/0,8mlSOL. INJ. IN PEN PREUMPLUT40mg/0,8mlSANDOZ GMBH - AUSTRIAL04AB04PR
HUKYNDRA 40mg/0,4mlSOL. INJ. IN SERINGA PREUMPLUTA40mg/0,4mlSTADA ARZNEIMITTEL AG - GERMANIAL04AB04PR
HUKYNDRA 40mg/0,4mlSOL. INJ. IN STILOU INJECTOR PREUMPLUT40mg/0,4mlSTADA ARZNEIMITTEL AG - GERMANIAL04AB04PR
HUKYNDRA 80mg/0,8mlSOL. INJ. IN SERINGA PREUMPLUTA80mg/0,8mlSTADA ARZNEIMITTEL AG - GERMANIAL04AB04PR
HUKYNDRA 80mg/0,8mlSOL. INJ. IN STILOU INJECTOR PREUMPLUT80mg/0,8mlSTADA ARZNEIMITTEL AG - GERMANIAL04AB04PR
HULIO 20 mgSOL INJ. IN SERINGA PREUMPLUTA20mg/0,4mlBIOSIMILAR COLLABORATIONS IRELAND LIMITED - IRLANDAL04AB04PR
HULIO 40 mgSOL INJ. IN PEN PREUMPLUT40mg/0,8mlBIOSIMILAR COLLABORATIONS IRELAND LIMITED - IRLANDAL04AB04PR
HULIO 40 mgSOL INJ. IN SERINGA PREUMPLUTA40mg/0,8mlBIOSIMILAR COLLABORATIONS IRELAND LIMITED - IRLANDAL04AB04PR
HUMIRA 20mg/0,2mlSOL. INJ. IN SERINGA PREUMPLUTA20mg/0,2mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AB04PR
HUMIRA 40mg/0,4mlSOL. INJ. IN PEN PREUMPLUT40mg/0,4mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AB04PR
HUMIRA 40mg/0,4mlSOL. INJ. IN SERINGA PREUMPLUTA40mg/0,4mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AB04PR
HUMIRA 40mg/0,8mlSOL. INJ.40mg/0,8mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AB04PR
HUMIRA 80mg/0,8mlSOL. INJ. IN PEN PREUMPLUT80mg/0,8mlABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIAL04AB04PR
HYRIMOZ 40 mg/0,4 mlSOL INJ. IN SERINGA PREUMPLUTA40mg/0,4mlSANDOZ GMBH - AUSTRIAL04AB04PR
HYRIMOZ 40 mg/0,4 mlSOL. INJ. IN PEN PREUMPLUT40mg/0,4mlSANDOZ GMBH - AUSTRIAL04AB04PR
HYRIMOZ 40mg/0,8mlSOL. INJ. IN PEN PREUMPLUT40mg/0,8mlSANDOZ GMBH - AUSTRIAL04AB04PR
IMRALDI 40mg/0,4mlSOL INJ. IN STILOU INJECTOR (PEN) PREUMPLUT40mg/0,4mlSAMSUNG BIOEPIS NL B.V. - OLANDAL04AB04PR
IMRALDI 40mg/0,4mlSOL. INJ. IN SERINGA PREUMPLUTA40mg/0,4mlSAMSUNG BIOEPIS NL B.V. - OLANDAL04AB04PR
IMRALDI 40mg/0,8mlSOL. INJ. IN PEN PREUMPLUT40mg/0,8mlSAMSUNG BIOEPIS NL B.V. - OLANDAL04AB04PR
IMRALDI 40mg/0,8mlSOL. INJ. IN SERINGA PREUMPLUTA40mg/0,8mlSAMSUNG BIOEPIS NL B.V. - OLANDAL04AB04PR
YUFLYMA 40mg/0,4mlSOL. INJ. IN SERINGA PREUMPLUTA40mg/0,4mlCELLTRION HEALTHCARE HUNGARY KFT. - UNGARIAL04AB04PR
YUFLYMA 40mg/0,4mlSOL. INJ. IN STILOU INJECTOR PREUMPLUT40mg/0,4mlCELLTRION HEALTHCARE HUNGARY KFT. - UNGARIAL04AB04PR
YUFLYMA 80mg/0,8mlSOL INJ. IN SERINGA PREUMPLUTA80mg/0,8mlCELLTRION HEALTHCARE HUNGARY KFT. - UNGARIAL04AB04PR
YUFLYMA 80mg/0,8mlSOL INJ. IN STILOU INJECTOR (PEN) PREUMPLUT80mg/0,8mlCELLTRION HEALTHCARE HUNGARY KFT. - UNGARIAL04AB04PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.